US2008176306A1PendingUtilityA1
Methods for Sterilizing Biological Materials
Est. expiryJul 22, 2013(expired)· nominal 20-yr term from priority
A61L 2103/09A61L 2/088A61L 2/08A61L 2/081A61L 2103/05A61L 2/00
56
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods are disclosed for sterilizing biological products to reduce the level of active biological contaminants such as viruses, bacteria, yeasts, molds, mycoplasmas and parasites.
Claims
exact text as granted — not AI-modified1 - 26 . (canceled)
27 . A method for reducing the level of active biological contaminants or pathogens in bone, comprising
contacting the bone with a composition comprising DMSO, trehalose and mannitol; and irradiating the bone-containing composition with gamma radiation,
wherein the total dose of gamma radiation is at least about 12 kGy.
28 . The method of claim 27 , wherein the bone-containing composition is below ambient temperature during irradiation.
29 . The method of claim 27 , wherein the bone-containing composition is at a temperature below its freezing point during irradiation.
30 . The method of claim 27 , wherein the irradiation is applied at a rate of at least about 0.1 kGy/hour to at least about 30.0 kGy/hour.
31 . The method of claim 27 , wherein the total dose of gamma irradiation is at least about 20 kGy.
32 . The method of claim 27 , wherein the total dose of gamma irradiation is at least about 26 kGy.
33 . The method of claim 27 , wherein the bone is demineralized bone matrix.
34 . The method of claim 27 , further comprising adjusting or maintaining the pH of the bone prior to irradiation.
35 . The method of claim 27 , further comprising reducing residual solvent content of the bone prior to irradiation.
36 . The method of claim 35 , wherein the residual solvent is a non-aqueous solvent.
37 . The method of claim 35 , wherein the residual solvent is an aqueous solvent.
38 . The method of claim 35 , wherein the residual solvent content is reduced to less than about 2.0%.
39 . The method of claim 27 , further comprising contacting the bone with at least one sensitizer prior to irradiation.
40 . The method of claim 27 , wherein the active biological contaminants or pathogens are selected from the group consisting of viruses, bacteria, yeasts, molds, parasites, prions and combinations thereof.
41 . The method of claim 27 wherein the bone is maintained in an inert atmosphere during irradiation.
42 . The method of claim 27 wherein the bone is maintained under vacuum during irradiation.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.